Showing results (1491-1500 of 1,631) with videos related to
Sort By:
Pageof 164
Experimental Eye Research|December 5, 2022
The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivoA L Minella, M I Casanova, T J Chokshi, et al.Journal of Virology|October 1, 2020
Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment FactorsNicole McAllister, Yan Liu, Lisete M Silva, et al.The Review of Scientific Instruments|March 6, 2014
Modulation of cosmic microwave background polarization with a warm rapidly rotating half-wave plate on the Atacama B-Mode Search instrumentA Kusaka, T Essinger-Hileman, J W Appel, et al.Journal of Intensive Care Medicine|March 7, 2024
Early Beta-Blocker Utilization in Critically Ill Patients With Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort StudyMargot Kelly-Hedrick, Sunny Yang Liu, Jordan Komisarow, et al.Inflammatory Bowel Diseases|July 11, 2026
Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like featuresCasey R Johnson, Lily Gillette, Qurbonali Qurbonov, et al.Nanoscale|July 5, 2017
One-pot synthesis of nanochain particles for targeting brain tumorsV S Perera, G Covarrubias, M Lorkowski, et al.JCO Clinical Cancer Informatics|March 21, 2023
Implementation of Systematic Financial Screening in an Outpatient Breast Oncology SettingMelissa P Beauchemin, David DeStephano, Rohit Raghunathan, et al.European Journal of Cancer (Oxford, England : 1990)|March 5, 2015
Are we ready to predict late effects? A systematic review of clinically useful prediction modelsTalya Salz, Shrujal S Baxi, Nirupa Raghunathan, et al.Anesthesia and Analgesia|February 9, 2024
Association of Early Dexmedetomidine Utilization With Clinical Outcomes After Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort StudySunny Yang Liu, Margot Kelly-Hedrick, Jordan Komisarow, et al.Thrombosis Research|September 30, 2021
Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosteroneMichael Oakes, Asad Arastu, Catherine Kato, et al.Pageof 164